2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II
2022-RA-932-ESGO Stereotactic body radiotherapy boost as an alternative for locally advanced cervical cancer when brachytherapy is not available, a prospective monocentric phase II